diabetes mellitus, type 2

Showing NaN - NaN of 133

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Diabetes, Type 2 Trial in Berlin (Semaglutide 3 mg, Semaglutide 7 mg, Semaglutide B 3 mg)

Completed
  • Diabetes Mellitus, Type 2
  • Semaglutide 3 mg
  • +7 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Nov 13, 2019

Diabetes, Type 2 Trial in Worldwide (Glimepiride, Metformin, Pioglitazone)

Terminated
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +33 more
Sep 25, 2019

Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)

Completed
  • Cardiovascular Disease
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +300 more
Sep 18, 2019

Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)

Completed
  • Diabetes Mellitus, Type 2
  • Human Insulin Inhalation Powder
  • Insulin Glargine
  • Fresno, California
  • +68 more
Sep 6, 2019

Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Injectable insulin)

Completed
  • Diabetes Mellitus, Type 2
  • Human Insulin Inhalation Powder
  • Injectable insulin
  • Sacramento, California
  • +42 more
Sep 6, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Diabetes, Diabetes, Type 2 Trial in Berlin (Semaglutide, Probenecid, Ciclosporin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Berlin, Germany
    Novo Nordisk Investigational Site
Jun 18, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +230 more
May 28, 2019

Diabetes, Diabetes, Type 2, Healthy Trial in Berlin (semaglutide, )

Completed
  • Diabetes
  • +2 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Jan 2, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Berlin (NNC9204-1513, Glucagon, Placebo)

Completed
  • Diabetes
  • +2 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Type 2 Trial in Worldwide (, linagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Sheffield, Alabama
  • +144 more
Jun 1, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin Glargine, Insulin Lispro)

Completed
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +155 more
Mar 16, 2018

Type 2 Diabetes, Diabetes, Type 2 Trial in United States (Biphasic Remogliflozin Etabonate, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • Biphasic Remogliflozin Etabonate
  • Placebo
  • Tucson, Arizona
  • +18 more
Jan 16, 2018

Diabetes, Type 2 Trial in Worldwide (GSK189075, pioglitazone, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +135 more
Nov 2, 2017

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, glyburide, metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +489 more
Nov 27, 2017

Diabetes, Type 2 Trial in Worldwide (GSK189075, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +156 more
Sep 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Anaheim, California
  • +131 more
Aug 25, 2017

Diabetes, Type 2 Trial in Argentina, Germany, United States (GSK189075, Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +3 more
Sep 1, 2017

Diabetes, Diabetes, Type 2 Trial in Austria, Germany, Switzerland (insulin detemir, insulin aspart, biphasic insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • +2 more
  • Graz, Austria
  • +126 more
Jun 26, 2017

Diabetes, Type 2 Trial in Worldwide (GSK1614235, Sitagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +8 more
Jun 7, 2017